Cargando…
Intravitreal Bevacizumab for Pseudophakic Cystoid Macular Edema; a Systematic Review
Cystoid macular edema (CME) is a major cause of decreased vision after complicated or uncomplicated cataract surgery. This paper reviews the use of intravitreal bevacizumab (IVB) injection for treatment of pseudophakic CME. In a literature search of all articles available on Medline and Scopus datab...
Autores principales: | Ghasemi Falavarjani, Khalil, Parvaresh, Mohammad-Mehdi, Modarres, Mehdi, Hashemi, Masih, Samiy, Nasrollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ophthalmic Research Center
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520593/ https://www.ncbi.nlm.nih.gov/pubmed/23264866 |
Ejemplares similares
-
Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal Neovascularization Associated with Age-related Macular Degeneration
por: Modarreszadeh, Mehdi, et al.
Publicado: (2008) -
Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019) -
Pars Plana Vitrectomy and Intravitreal Phacoemulsification for Dropped Nuclei
por: Ghasemi Falavarjani, Khalil, et al.
Publicado: (2012) -
Evaluation of Predictive Factors for Successful Intravitreal Dexamethasone in Pseudophakic Cystoid Macular Edema
por: Kakkassery, Vinodh, et al.
Publicado: (2017) -
Pseudophakic cystoid macular edema: update 2016
por: Grzybowski, Andrzej, et al.
Publicado: (2016)